Echo IQ is trading 10.68% up at A$0.57 after a highly volatile week.

  • The stock fell 50.00% on September 9 before rebounding 11.34% on September 15.
  • Echo IQ released an EchoSolv HF FDA application update on September 17, but ASX did not mark it price-sensitive, and substantive details were unavailable in the accessible listing.
  • The move therefore appears to be a volatile rebound rather than a confirmed catalyst.